My watch list  

Proteasome inhibitor

  Proteasome inhibitors are drugs that block the action of proteasomes, cellular complexes that break down proteins, like the p53 protein. Proteasome inhibitors are being studied in the treatment of cancer. In 2003, bortezomib was the first proteasome inhibitor to be approved for use in the U.S.

A derivative of epigallocatechin-3-gallate has been proposed as another proteasome inhibitor.[1]


  1. ^ Osanai K, Landis-Piwowar KR, Dou QP, Chan TH (2007). "A para-amino substituent on the D-ring of green tea polyphenol epigallocatechin-3-gallate as a novel proteasome inhibitor and cancer cell apoptosis inducer". doi:10.1016/j.bmc.2007.05.041. PMID 17544279.
This article is licensed under the GNU Free Documentation License. It uses material from the Wikipedia article "Proteasome_inhibitor". A list of authors is available in Wikipedia.
Your browser is not current. Microsoft Internet Explorer 6.0 does not support some functions on Chemie.DE